These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24105298)

  • 1. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
    Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
    Prion; 2013; 7(5):434-9. PubMed ID: 24105298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.
    Madampage CA; Määttänen P; Marciniuk K; Brownlie R; Andrievskaia O; Potter A; Cashman NR; Lee JS; Napper S
    Prion; 2013; 7(4):301-11. PubMed ID: 23787697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion diseases and emerging prion diseases.
    Yokoyama T; Mohri S
    Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses.
    Hedlin PD; Cashman NR; Li L; Gupta J; Babiuk LA; Potter AA; Griebel P; Napper S
    Vaccine; 2010 Jan; 28(4):981-8. PubMed ID: 19925901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of antibody fragments for immunotherapy of prion diseases.
    Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
    Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
    Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
    Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope.
    Taschuk R; Marciniuk K; Määttänen P; Madampage C; Hedlin P; Potter A; Lee J; Cashman NR; Griebel PJ; Napper S
    Prion; 2014; 8(1):51-9. PubMed ID: 24509522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
    Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
    FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
    Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.
    Wei X; Roettger Y; Tan B; He Y; Dodel R; Hampel H; Wei G; Haney J; Gu H; Johnstone BH; Liu J; Farlow MR; Du Y
    J Biol Chem; 2012 Apr; 287(16):12858-66. PubMed ID: 22362783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
    Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
    Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multivalent, PrP(Sc)-specific prion vaccine through rational optimization of three disease-specific epitopes.
    Marciniuk K; Määttänen P; Taschuk R; Airey TD; Potter A; Cashman NR; Griebel P; Napper S
    Vaccine; 2014 Apr; 32(17):1988-97. PubMed ID: 24486363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunoreactivity of goat derived scrapie following in vitro misfolding versus mouse bioassay.
    Madsen-Bouterse SA; Zhuang D; O'Rourke KI; Schneider DA
    Biochem Biophys Res Commun; 2012 Jul; 423(4):770-4. PubMed ID: 22713450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
    Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
    Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.